Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7651976 | 0.81 | KMT2A (0.37) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7651968 | 0.79 | KDM4E (0.40) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7663615 | 0.78 | SIRT6 (0.30) | — | |
| SCHEMBL7659400 | 0.78 | AKR1C3 (0.39) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7654022 | 0.77 | P4HTM (0.35) | KMT2AKDM4EMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL7654547 | 0.77 | KMT2A (0.36) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7656151 | 0.74 | CASP3 (0.34) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7663915 | 0.73 | CYP1A2 (0.36) | KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL7662443 | 0.71 | KMT2A (0.36) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 | |
| SCHEMBL7654546 | 0.70 | KMT2A (0.38) | KMT2AKDM4EMEN1ALDH1A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6399613-B1 | N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES | AVENTIS PHARMA S.A. (FR) | 2002-06-04 | — | — | US | claimed |
| US-6399613-B1 | N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES | AVENTIS PHARMA S.A. (FR) | 2002-06-04 | — | — | US | disclosed |